| Unique Award Key |
CONT_AWD_75A50123C00065_7505_-NONE-_-NONE-
|
| Awarding Agency |
Department of Health and Human Services
|
| Link |
View Page
|
Award Amounts
| Obligated Amount |
8294985.00 |
| Current Award Amount |
8294985.00 |
| Potential Award Amount |
338869093.00 |
Description
| Title |
THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION J, ATTACHMENT #1 ? STATEMENT OF WORK TO REMOVE WBS 1.2.10.6, 1.2.10.7 AND UPDATE ATTACHMENT #9, PART I DELIVERABLES AND BARDA MILESTONE PAYMENT SCHEDULE. THE OVERALL CONTRACT VALUE IS REDUCED FROM |
| NAICS Code |
541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Product and Service Codes |
AN13: HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
Recipient Details
| Recipient |
CASTLEVAX INC |
| UEI |
FLZ6THBQ53N3 |
| Recipient Address |
UNITED STATES, 175 VARICK ST RM 608, NEW YORK, NEW YORK, NEW YORK, 100144604 |
|
